STEVENSON, Md., Dec. 28, 2016 -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of Indiana on behalf of purchasers of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) (“Zimmer” or the “Company”) securities during the period between September 7, 2016 and October 31, 2016, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until January 31, 2017 to seek appointment as lead plaintiff.
If you wish to choose counsel to represent you and the Class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the Class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in Zimmer securities during the Class Period. Members of the Class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action.
The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants’ failure to disclose during the Class Period that supply chain problems led to a decrease in order fulfillment rates, most notably within Zimmer’s knee and hip portfolios and the Company would not achieve its revenues and profit forecast.
According to the complaint, following an October 31, 2016 press release and conference call disclosing that sales weakness stemming from a change in the supply chain infrastructure, which led to shortfalls in the availability of implants and instrument sets during the quarter, the value of Zimmer shares declined significantly.
If you have suffered a loss in excess of $100,000 from investment in Zimmer securities purchased on or after September 7, 2016 and held through the revelation of negative information during and/or at the end of the Class Period and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or obligation to you, please visit our website at http://www.browerpiven.com/currentsecuritiescases.html. You may also request more information by contacting Brower Piven either by email at [email protected] or by telephone at (410) 415-6616. Brower Piven also encourages anyone with information regarding the Company’s conduct during the period in question to contact the firm, including whistleblowers, former employees, shareholders and others.
Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s. If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice. You need take no action at this time to be a member of the class.
CONTACT: Charles J. Piven Brower Piven, A Professional Corporation 1925 Old Valley Road Stevenson, Maryland 21153 Telephone: 410-415-6616 [email protected]


Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper
HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model
CMOC to Acquire Equinox Gold’s Brazilian Mines in $1 Billion Deal to Expand Precious Metals Portfolio
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 



